JAK2 protein tyrosine kinase And NotRadek C. Skoda

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
003387	N. C. P. Cross [Royaume-Uni] ; G. Q. Daley [États-Unis] ; A. R. Green [Royaume-Uni] ; T. P. Hughes [Australie] ; C. Jamieson [États-Unis] ; P. Manley [Suisse] ; T. Mughal [Royaume-Uni] ; D. Perrotti [États-Unis] ; J. Radich [États-Unis] ; R. Skoda [Suisse] ; S. Soverini [Italie] ; W. Vainchenker [France] ; S. Verstovsek [États-Unis] ; J.-L. Villeval [France] ; J. M. Goldman [Royaume-Uni]	BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders : some common and contrasting features
003556	Michelle B. Hookham [Royaume-Uni] ; Joanne Elliott [Royaume-Uni] ; Yvonne Suessmuth [Royaume-Uni] ; Judith Staerk [Belgique] ; Alister C. Ward [Australie] ; William Vainchenker [France] ; Melanie J. Percy [Royaume-Uni] ; Mary Frances Mcmullin [Royaume-Uni] ; Stefan N. Constantinescu [Belgique] ; James A. Johnston [Royaume-Uni]	The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024